http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_894a15c4125238ea75d16a796d8c2e9f
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | L Murray Murray |
| name | James L. Murray James L Murray |
| given-name | James L James L. James |
| organization-name | From the Departments of Clinical Cancer Prevention, Biostatistics, Breast Medical Oncology, Pathology, and Epidemiology, The University of Texas M.D. Anderson Cancer Center, Houston, TX; and Department of Pathology, Arizona Cancer Center, The University of Arizona, Tucson, AZ From the Departments of Breast Medical Oncology, Department of Biostatistics, and the Division of Medicine and Pathology of the University of Texas M.D. Anderson Cancer Center, Houston TX; and Cell Pathways Inc, Horsham, PA. From the Mayo Clinic, Rochester, MN; the Division of Hematology/Oncology and Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL; IDEC Pharmaceuticals Corporation, San Diego, CA; the Washington University, St Louis, MO; Fox Chase Cancer, Philadelphia, PA; MD Anderson Cancer Center, Houston, TX; and the University of Alabama, Birmingham, AL. University of Georgia, College of Veterinary Medicine, Department of Infectious Diseases, Athens, Georgia From the Department of Medicine, Division of Hematology and Medical Oncology, Naval Medical Center San Diego, San Diego, CA; Department of Surgery, General Surgery Service, Brooke Army Medical Center, Fort Sam Houston; The University of Texas, M.D. Anderson Cancer Center, Houston, TX; Department of Medicine, Hematology and Medical Oncology Service, Walter Reed Army Medical Center, Washington, DC; Cancer Vaccine Development Program, United States Military Cancer Institute, Department of Surgery, Uniformed... Zirus, Inc., Buford, Georgia. Work Healthy Australia, Australia. Division of Cancer Medicine, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston Takayuki Iwamoto, Daniel Booser, Vicente Valero, James L. Murray, Kimberly Koenig, Francisco J. Esteva, Naoto T. Ueno, Jie Zhang, Weiwei Shi, Yuan Qi, Elliana J. Yang, Gabriel N. Hortobagyi, W. Fraser Symmans, and Lajos Pusztai, The University of Texas MD Anderson Cancer Center, Houston, TX; Takayuki Iwamoto and Junji Matsuoka, Okayama University, Okayama, Japan; and Christos Hatzis, Nuvera Biosciences, Woburn, MA. Department of Breast Medical Oncology The University of Texas MD Anderson Cancer Center Houston Texas From the Departments of Urology, Clinical Immunology and Biologic Therapy, and Nuclear Medicine, The University of Texas M. D. Anderson Hospital and Tumor Institute at Houston, Houston, Texas; Hybritech, Inc., San Diego, California National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 30333 ¶Bioimmunotherapy, University of Texas M. D. Anderson Cancer Center, Houston, TX 77030; and Authors' Affiliations: Departments of 1Melanoma Medical Oncology, 2Breast Medical Oncology, and 3Stem Cell Transplantation, University of Texas, MD Anderson Cancer Center; 4Graduate Program in Immunology, University of Texas Graduate School of Biomedical Sciences; 5M.D./Ph.D Program, University of Texas Medical School at Houston, Houston, Texas; and 6Department of Immunology, Institute of Medical Microbiology and Hygiene, University of Freiburg, Freiburg, Germany From the Division of Internal Medicine and Hematology and the Department of Radiology, Nuclear Medicine, Mayo Clinic and Mayo Foundation, Rochester, MN; IDEC Pharmaceuticals Corporation, San Diego, and University of California Los Angeles Medical Center, Los Angeles, CA; Division of Hematology/Oncology and The Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL; M.D. Anderson Cancer Center, Houston, TX; and Western Pennsylvania Cancer Institute, Pittsburgh, PA. Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston Department of Gynecologic Oncology, Surgical Oncology, Breast Medical Oncology and Immunology, M. D. Anderson Cancer Center, Houston, Texas 77030 Department of Breast Medical Oncology and Bioimmunotherapy, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030 Zirus, Inc., Buford, GA, USA Department of Bioimmunotherapy, M. D. Anderson Cancer Center, Houston, Texas 77030, USA. Department of Clinical Immunology and Biological Therapy, The University of Texas M.D. Anderson Cancer Center at Houston , Houston Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA Department of Bioimmunotherapy, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030. 1Bioimmunotherapy, Departments of From the Departments of Breast Medical Oncology, Ophthalmology, Laboratory Medicine, Pathology, and Biostatistics, The University of Texas M.D. Anderson Cancer Center, Houston, TX. 2Breast Medical Oncology, and Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston From the Departments of Breast Medical Oncology, Molecular and Cellular Oncology, Blood and Marrow Transplantation, Gynecological Oncology, Thoracic Surgery, Pathology, and Bioimmunotherapy, and Section of Immunobiology and Drug Carriers, The University of Texas M.D. Anderson Cancer Center, Houston; RGene Therapeutics, Inc, Woodlands, TX; Department of Internal Medicine, Medical Oncology, Rush-Presbyterian St Luke’s Medical Center, Chicago, IL; Department of Pharmacology, University of Pittsburgh School... |
Incoming Links
Total number of triples: 137.